Videos

Jim Demarest discusses innovations focused on advancing novel treatments that require less frequent dosing and attempt to achieve HIV cure.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses common misconceptions about provider diversion.

This audio series discusses the role of health care providers in supporting adherence among adolescents living with HIV.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses what actions some institutions have taken to curb drug diversion among health care providers.

A clinical pharmacy specialist talks about care and medication treatment for patients living with HIV.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses how pharmacists can mitigate risks associated with handling hazardous drugs in the operating room.

Raulo Frear, PharmD, general manager of OmedaRx, discusses the high initial cost of hepatitis C drugs like Sovaldi compared with the long term cost of treating the disease.

Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how technology can improve care coordination in oncology pharmacy.

Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how technology and remote medication preparation help improve oncology pharmacy.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses what diversion signs should be on an operating room pharmacist's radar.

Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how health information technology rules improve oncology clinic practices.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses how pharmacists can prevent drug diversion in the operating room.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses which care providers benefit the most from the operating room pharmacist's USP knowledge.

Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses the advantages of including investigational agents in pharmacy workflows.

Peggy Bickham, PharmD, assistant director at the University of Illinois Hospital, discusses why compliance with USP is critical in the operating room.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses key considerations for treating delirium in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses sleep's role in treating patients in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses what he's learned from using sedation for pain and delirium in critically ill patients.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses delirium risk factors pharmacists should consider when handling patients in the ICU.

Ashley Feldt, PharmD, MBA, director of pharmacy, oncology at Aurora Health Care discusses how her organization has handled investigational agents in pharmacy workflow.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses which non-pharmacologic treatments pharmacists should consider when caring for patients in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses key concepts pharmacists should consider when selecting sedatives, analgesics, and antipsychotics for critically ill patients.

Hae Mi Choe, PharmD, explains how metrics and tools create areas of opportunity for pharmacists.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses how pharmacists can help detect delirium in the ICU.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses current practice guidelines for pain and delirium that would be important for pharmacists.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses what elements pharmacists should consider when detecting delirium in the ICU.

Erin Fox, PharmD, director at the University of Utah Drug Information Service, discusses how pharmacists can rationalize the need to compound or import drugs that are in short supply.

John W. Devlin, PharmD, FCCM, FCCP, a clinical pharmacist in the medical ICU at Tufts Medical Center, discusses current attitudes regarding drug-induced coma in the ICU.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in copay and reimbursement assistance that specialty pharmacies need to be aware of.

Hae Mi Choe, PharmD, describes how pharmacists can use metrics for reimbursement recognition.